Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Luspatercept in Metastatic Adult Granulosa Cell Tumor (AGCT) of the Ovary

NCT06254781 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT06254781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06254781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Luspatercept in Metastatic Adult Granulosa Cell Tumor (AGCT) of the Ovary
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Completed
Start date
May 30, 2022
Completion date
August 29, 2022
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult granulosa cell tumor of the ovary